Research Roundup

OFFICIAL PUBLICATION OF

by its subsidiary APPco

Debbie Rigby 17/04/2018

Debbie Rigby takes a look at the latest in research news Dipeptidyl peptidase-4 inhibitors and incidence of inflammatory bowel disease among patients with type 2 diabetes A large UK-based cohort study has shown the use of dipeptidyl peptidase-4 inhibitors is associated with an increased risk of inflammatory bowel disease in patients with type 2 diabetes.

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

‘Consumer confusion, pharmacist frustration’ if current system continues

The first and foremost role of "expanded scope" is the HMR and collaborative medication management. A clear no brainer which…

Big Pharma

‘I can feel the walls closing in on me as this snowballs’

I'm yet to encounter a corporate provider, Debbie, with the benefits you describe around quality improvement with the corporate business…

Kelly Abbott

‘Consumer confusion, pharmacist frustration’ if current system continues

I welcome Mark's move, at least someone talks about it. But like any push at the forefront, it comes with…

Benjamyn Sung

‘I can feel the walls closing in on me as this snowballs’

I would argue quality varies in any profession. Most GPs will not refer to a provider where the quality is…

Big Pharma

Research Roundup

Previous Unseasonal conditions

Next App helps compliance, but not blood pressure

In the beginning

The signs of ageing

Hyperpigmentation

How to avoid dry skin

MENU

Previous Unseasonal conditions

Next App helps compliance, but not blood pressure

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.